Inhibiting transient protein-protein interactions: lessons from the Cdc25 protein tyrosine phosphatases.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17287826.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transient protein-protein interactions have key regulatory functions in many of the cellular processes that are implicated in cancerous growth, particularly the cell cycle. Targeting these transient interactions as therapeutic targets for anticancer drug development seems like a good idea, but it is not a trivial task. This Review discusses the issues and difficulties that are encountered when considering these transient interactions as drug targets, using the example of the cell division cycle 25 (Cdc25) phosphatases and their cyclin-dependent kinase (CDK)-cyclin protein substrates.
Medical subject headings
- Cyclin-Dependent Kinases
- Enzyme Inhibitors
- Signal Transduction
- cdc25 Phosphatases